Anthony Stein is a Hematology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 13 publications with 205 citations (h-index 4); ClinicalTrials.gov lists 11 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Duarte Rd
Duarte, CA 91010
Telephone
626-256-4673Provider last certified this registry record 23 Mar 2022.
Clinical trials
- Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
Sponsor: City of Hope Medical Center
- Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia
Sponsor: City of Hope Medical Center
- Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
Sponsor: City of Hope Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202522 payments$14,438openpaymentsdata.cms.gov ↗
- Syndax Pharmaceuticals, Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2016–2018 per NIH RePORTER. The latest:
- Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
Beckman Research Institute/city of Hope
FY2018$238,425R01CA195519 - Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
Beckman Research Institute/city of Hope
FY2017$272,213R01CA195519 - Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
Beckman Research Institute/city of Hope
FY2016$272,213R01CA195519
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Role of Transplant for Philadelphia-positive B-cell Acute Lymphoblastic Leukemia in 2025
Current Oncology Reports
2025 - The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B‐ <scp>ALL</scp> With High Disease Burden
American Journal of Hematology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Yuman Fong, MD
City Of Hope National Medical Center
Ravi Salgia, MD, PhD
City Of Hope National Medical Center
Stephen Gruber, MD
City Of Hope National Medical Center
Tanya Siddiqi, MD
City Of Hope National Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”